F Mirum Pharmaceuticals, Inc. Transaction History
F
- $2.27 Billion
- Q2 2025
A detailed history of F transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, F holds 28,556 shares of MIRM stock, worth $2.08 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
28,556Holding current value
$2.08 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
230Shares Held
56.1MCall Options Held
25.3KPut Options Held
98.9K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$496 Million18.24% of portfolio
-
Janus Henderson Group PLC London, X05.24MShares$382 Million0.14% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$236 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$201 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$192 Million2.55% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.68B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...